Global Point-Of-Care Or Rapid Diagnostics Market Growth 2023-2029

Global Point-Of-Care Or Rapid Diagnostics Market Growth 2023-2029

Product Code:460577

Published Date: Feb 08,2023

Pages: 129

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.

In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.

LPI (LP Information)' newest research report, the “Point-Of-Care Or Rapid Diagnostics Industry Forecast” looks at past sales and reviews total world Point-Of-Care Or Rapid Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-Of-Care Or Rapid Diagnostics sales for 2023 through 2029. With Point-Of-Care Or Rapid Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-Of-Care Or Rapid Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Point-Of-Care Or Rapid Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-Of-Care Or Rapid Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-Of-Care Or Rapid Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-Of-Care Or Rapid Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-Of-Care Or Rapid Diagnostics.

The global Point-Of-Care Or Rapid Diagnostics market size is projected to grow from US$ 25110 million in 2022 to US$ 48170 million in 2029; it is expected to grow at a CAGR of 48170 from 2023 to 2029.

In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.

In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.

This report presents a comprehensive overview, market shares, and growth opportunities of Point-Of-Care Or Rapid Diagnostics market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Intensive Care
    Covid-19 Testing
    Infectious Diseases Testing
    Cardiac Markers Testing
    Coagulation Testing
    Others

Segmentation by application
    Hospital
    Clinic
    Independent Laboratories
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Roche
    Abbott
    Danaher
    Siemens Healthcare
    Bio-Rad Laboratories
    BioMerieux
    Nova Biomedical
    Thermo Fisher Scientific
    Quidel
    A. Menarini Diagnostics
    Becton Dickinson
    Biosurfit
    Astrego Diagnostics
    Werfen
    Abionic
    Palex Medical/Bülhmann
    Horiba Medical
    RAL
    Vircell
    Monlab
    Binding Site

Key Questions Addressed in this Report
What is the 10-year outlook for the global Point-Of-Care Or Rapid Diagnostics market?
What factors are driving Point-Of-Care Or Rapid Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-Of-Care Or Rapid Diagnostics market opportunities vary by end market size?
How does Point-Of-Care Or Rapid Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?